In the COVID-19(−) virus group there was a high positive correlation between the percentage of RE-LYMP and proportion of CD4+ CD38+ cells (R = 0.7, p < 0.05) and between the percentage of RE-LYMP and GMF CD4+ CD38+ intensity (R = 0.8, p < 0.05). This evidence concerns the gene CD4 and COVID-19.